• 1. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 2. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

Introduction to 3-Ethyl-1H-pyrrolo[2,3-b]pyridine (CAS No. 10299-74-8)

3-Ethyl-1H-pyrrolo[2,3-b]pyridine, with the CAS number 10299-74-8, is a heterocyclic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrrolopyridines, which are known for their diverse biological activities and potential therapeutic applications. The unique structural features of 3-Ethyl-1H-pyrrolo[2,3-b]pyridine make it a valuable scaffold for the development of novel drugs targeting various diseases.

The chemical structure of 3-Ethyl-1H-pyrrolo[2,3-b]pyridine consists of a fused pyrrole and pyridine ring system, with an ethyl group attached at the 3-position. This arrangement provides a rigid and planar structure that can interact with biological targets in specific and predictable ways. The presence of the nitrogen atoms in the pyrrole and pyridine rings also confers basic properties to the molecule, which can influence its solubility, stability, and binding affinity to receptors.

In recent years, extensive research has been conducted to explore the biological activities of 3-Ethyl-1H-pyrrolo[2,3-b]pyridine. One of the most notable areas of interest is its potential as an inhibitor of kinases, a family of enzymes that play crucial roles in cellular signaling pathways. Kinases are involved in various physiological processes, including cell growth, differentiation, and apoptosis. Dysregulation of kinase activity is often associated with diseases such as cancer, inflammation, and neurodegenerative disorders.

A study published in the Journal of Medicinal Chemistry in 2021 reported that 3-Ethyl-1H-pyrrolo[2,3-b]pyridine-based compounds exhibited potent inhibitory activity against several kinases, including ABL1 and SRC. These findings suggest that 3-Ethyl-1H-pyrrolo[2,3-b]pyridine derivatives could be developed into effective therapeutic agents for treating kinase-driven diseases. The researchers also noted that the ethyl group at the 3-position played a critical role in enhancing the potency and selectivity of these compounds.

Beyond kinase inhibition, 3-Ethyl-1H-pyrrolo[2,3-b]pyridine has shown promise in other therapeutic areas as well. For instance, a 2020 study published in Bioorganic & Medicinal Chemistry Letters demonstrated that certain derivatives of this compound exhibited significant anti-inflammatory activity by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. This property makes 3-Ethyl-1H-pyrrolo[2,3-b]pyridine-based compounds potential candidates for treating inflammatory diseases like rheumatoid arthritis and Crohn's disease.

In addition to its biological activities, the synthetic accessibility of 3-Ethyl-1H-pyrrolo[2,3-b]pyridine is another factor that contributes to its appeal as a drug development scaffold. Several efficient synthetic routes have been reported for the preparation of this compound and its derivatives. One such method involves a palladium-catalyzed cross-coupling reaction between a halopyrrole derivative and an ethyl-substituted pyridine. This approach allows for the facile introduction of various functional groups at different positions on the pyrrolopyridine core, enabling the rapid synthesis of diverse analogs for biological evaluation.

The pharmacokinetic properties of 3-Ethyl-1H-pyrrolo[2,3-b]pyridine-based compounds have also been investigated to ensure their suitability for in vivo studies. A study published in European Journal of Medicinal Chemistry in 2019 reported that certain derivatives exhibited favorable oral bioavailability and metabolic stability. These findings indicate that these compounds could be administered orally as potential therapeutic agents.

In conclusion, 3-Ethyl-1H-pyrrolo[2,3-b]pyridine (CAS No. 10299-74-8) is a versatile heterocyclic compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features and diverse biological activities make it an attractive scaffold for the development of novel drugs targeting various diseases. Ongoing research continues to uncover new applications and optimize the properties of this promising compound.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)